As approved by the China Food and Drug Administration, CKI can be employed for cancer treatment (Guo et al., 2015) and has several pharmacological functions, including anticancer properties, hemostasis, and immunity enhancement (Wang et al., 2015). Here, CHKA is linked to cancer.